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1. INTRODUCTLON 2, MATERIALS AND METHODS 
Voltage regulated L-type calcium channels are widely 
distributed in many excitable cells of tissues such as 
skeletal, cardiac, and smooth muscle or brain. These 
channels have high affinity binding sites for a variety of 
drugs, e.g. 1,4-dihydropyridines, phenylalkylamines, 
bcnzothiazepines, and diphenylbutylpiperidincs tc, 
(see [I] for review). The 1,4-dihydropyridines (DHP) 
are among the most useful ligands to identify the L- 
type calcium channels even in broken cell preparations, 
DHP binds to the a-1 subunit of the L-type channels 
[2]. Since the primary structures of cr-1 subunits from 
various tissues (skeletal, cardiac, and smooth muscle) 
are known [3-51, it is a nmjor goal to identify the DHP 
binding site(s) within the primary amino acid se- 
quences, 
Photoaffinity labeling plays an essential role to 
achieve this goal. Previously we have reported several 
reagents [&?‘I and toxin derivatives for specifically 
photolabeling the sodium channels [G-10]. Recently we 
have synthesized iazipine (Fig. l), a novel photoreac- 
tive derivative of DHP possessing a phenyldiazirine as 
a carbene precursor [ll]. In this paper we describe the 
properties of diazipine, in terms of binding and 
photolabeling of the a-1 subunit in purified prepara- 
tion of caldium channels from rabbit skeletal muscles. 
By comparison with azidopine, the currently used 
photoreactive DHP [Ia] characteristics of diazipine in 
binding affinity, photoincorporation efficiency, and 
photoproduct stability will also be described. 
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3. I I Mllreticll$ 
[‘HlDiaaipirre (21,2 Cilrnmol) and iinlnb~ldd diazipinc were 
grt?piWA LO described in [1 I]. [‘H]Aridopinc (53.0 CVmmal) and 
[“I-!]( * )PNZO&l IQ were purchucd from Amcrahm and NEN, 
refpccrivcly. Unlabeled (~)PN300~110 was provided from Stmdoz 
(Switzerland). 
2,2. Prepnrarion a/ Ihe WC%-Sepirsrose puri/ird ealchtm channels 
Digitonin extraaS of purified I.tubulc fractions from rabbit 
skeletal muscles were purified by a WOA-Sepharosc chromatography 
IS dcscribcd in tlrc litcraturc [3]. The IV-acclylglucosaminc eluatcs 
(specific binding activity of [%I( t )PNIOQ-1 0: 530-800 pmol/mg 
of protein) were used without further purification. 
3.3. Bitrdirtg experinren ts 
Into the WGA-purified calcium channels (4~41: of protein) in 
50 mM TrisXl (pH 7,4) containing 2 mM CaC12, IOOrM cis- 
diltiazcm, and 0.1% digitonin ‘binding buffer’, (“Hlcliazipine was 
added in various concentrations (l-80 nM) and final volumes were 
5004, The mixture was incubated at 25% for I h in the dark, Two 
100 cl aliquots of the incubates were loaded on a Scphadex G-50 
(fine) column (2 ml) which was pre-equilibrated with the binding buf- 
fcr and gel-filtrated by ccntrifugation as described [l3]. Radioactivity 
of the filtrate was measured by scintillation counting, Binding in the 
presence of IO PM (&)PN200-1 IO was also carried out to measure 
non-specific binding, Duplicate runs were performed for each data 
point. For competitive binding experiments, unlabeled ligand 
(0.1 nM-IOBM) of either diazipine or (*)PN200-110 was incubated 
with 3.4 nM f3H]( +)PN200-110 and the purified calcium channel 
(1.9~6 of protein). Subsequent gel-filtration was carried out 
similarly. 
2.4. Photoaffinity lubeling 
The WGA-purified calcium channel (30lrg/ml, 23 nM of DWP 
sites) was incubated with 11 nM of [‘Hjdiazipine or [“Hlazidopine in 
the binding buffer for 1 la at 25’C in the dark. An aliquot of the mix- 
ture was incubated in the presence of 10 pM (&))PN300-110 to deter- 
mine nonspecific phoioSabeiing. The incubation mixtures were 
transferred into plastic Petri dishes on ice and irradiated with a 
Panasonic 20W black light-blue lamp (5 cm distance) for 30 min. 
After photolysis the samples were dialysed against deionized water 
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Fig. I, Chcmierl IIruc\urr of (‘Hldiaxipine. 
Hlld eenccnwwcd ivitlr Ccnrricon 30 (hmlcen). SQS=PAUB WY cw 
rirtl 0~1 wceerdino 10 Larmmli 114) trslng 8% p0l~~crylrmltlc r0r Ihe 
xcparrtlon gel. The conccnrratcd ~mpkr wcrQ incukarod in Ihe ram- 
plc hlrfet far SBWAC3E cenlrirrlng cirhrr $0 mM b!= 
c~lrylmnlcimide (NEM) or 50 mM diWxhrcirel (BTT) for 2 h 81 
4WZ and leedrd onto the gel. After rketrophare~ir, individurl gtl 
lencs wcrc mnnually cut into 3 mm slicer which Wcfc uM-dlined wirh Frao (nfvl) 
30% W&O1 (0.75 ml) et 7O’C and counted. 
Fig. 3. Swration ire~lrrrm of (‘Hldi~xiplnc binding0 [LHtBin;sipine 
(wal conccnrration I-ICI IN) was ineubared wiih 4 erg of the WGA- 
3. RESULTS AND DISCUSSION 
purified prntcln. Yawtl binding (a), rranxascifk bindina (a), wntl 
apccific binding (m) are shown. Dare painto we means of duplicate 
Binding properties of diazipinc and (‘Hjdiazipinc 
dr~crmirrtrtiana. Tlrc rpdfic bindlna eomponcntr were anrlyned by B 
Sontc‘hard pkx (drpiwd in inrcrt)and rcrulting in Q &of 9.3 nM mtd 
were studied in two systems. First, diazipine com- 63,,, of 6.16 nM (or 770 pmul/mg protein). 
pctitively blocked the binding of [‘H]( +)PN200-110 to 
the WGA-Sepharosc purified DHP receptor from rab- 
bit skeletal muscle. The obtained ICsa value was. conventional dihydropyridines, racemic 
16.3 nM (Fig, 2). Hill coefficient (r&i) was 1.00, sug- (‘Hlazidopine and a biologically act:;:’ enantiomcr 
gesting a single binding mode. The value of I& is com- [3H]( +)PN200.118, 10.5 nM and 5.2 nM respectively, 
parable to that of (rt)l?N200-110, 20.4 nM which is which were seprlrately determined to the same prepara- 
obtained by the parallel experiment (Fig, 2). tion, A fairly high level of nonspecific binding of 
In the second binding system, [‘HJdinzipinc-bound [‘Mjdiazipinc to the purified receptors might be ex- 
fraction in the purified receptor preparation was in- plaincd in terms of the more hydrophobic haracter of 
creased in a saturable fashion by increasing the the compound since it was retained much longer 
[3H]diazipine concentrations, although the nonspecific (15 min) on a Cl 8 revcrscd phase column of HPLC 
binding fraction was fairly high (Fig. 3). Scatchard than either azidopine (12 min) or PN200-110 (9 min). 
analysis of the specific binding fraction showed a single However, this nature is not an obstacle when 
binding mode (insert in Fig. 3) and gave the values of [3H]diazipine isapplied to the photoaffinity labeling of 
& = 9.3 nM and B,,,,, = 770 pmol/mg of protein. The the receptor. As shown in Fig. 4, the reagent was 
Kd value obtained was comparable with those of the specifically incorporated into the 150 kDa polypcptide, 
and any of other polypeptides in the preparation which 
were apparently seen in the silver-stained gel of SDS- 
-- 
1 
PAGE, were not labeled at all. The specific manner of 
the incorporation was also demonstrated by another ex- 
periment where the photoincorporation was completely 
blocked in the presence of excess amount of 
PN200-110, one of the typical and specific reversible 
dihydropyridine ligands for the receptor. 
The 150 kDa polypeptide labeled with t3H]diazipine 
did not change its size on SDS-PAGE after reducing 
with dithiothreitol (Figs. 4,5), as in the case of 
[3H]azidopine (Fig. 5). It has been established that the 
* 150 kDa polypeptide labeled with [3H]aaidopine is the 
*ll -10 .6 .*5 
beg{ [ LigHBnc! ] (M;} 
a-1 subunit of the L-type calcium channel [2,3]. 
Therefore, i3H]diazipine also labels the a-l subunit 
\ . 
Fig. 2. Inhibition f [“H]( t )PN200-110 binding by two photoaffinity 
(dihydropyridine receptor) and we conclude that 
IIgands of DHP. WOA-purified calcium channel preparations from diazipine is a new photoaffinity probe for the 
rabbit skeletal muscle (1.9pg of protein) were incubated with 3,4 nM dihydropyridine binding site of the calcium channels. 
13H1( + )PN200-110 in the presence of the indicated concentrations of Photoincorporation efficiency of [3H]diazipine 
unlabeled diazipine (a), or PN200-110 (0). (Fig. 5a) is 2 times as high as that of [31-I]azidopine 
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Fig. 4, Photoaffinity labeling of the DHP rcccprora with 
[‘H]dinxipinc. The WSAqxirificd DHP rcccptorle wcrc incubrrcd 0 
with I I nM of (‘~jdiazil~inc(~quarcrytnbal), or I I rrM [‘Wjdiazipinc 5 10 15 20 5 10 15 20 
plus LO&l (t)PNZOOsl 10 [circle aymbot) for I tr tu ZS’C, and the Slice No. 
mixwc was rhcn photolyzcd. After dialyrir and conccntmtion, the 
phowlyzed sample (l0.S jrg protein or II pmol of DWP binding rite) Fig. 5. Camperiron of the phorolabclcd DHP rcccptor proreins rvith 
was rrca!cd cithcr with 50 nrM NEM (open symbol) or with 50 mhl [‘Hldiazipinc and [‘HJaaidopinc. The receptor proteins, 30% of 
DTT (filled symbol) and clcctropkorcscd, Silver-sraincd protein which were bound reversibly with [‘Hldinzipinc (a, b) or 
profiles arc shown in the upper panel. In rkc gel slices 6-9, [‘Hlazidopinc (c, d) wcrc phorolyzcd. The photolyzcd samples 
radioisotope wax rpccificolly incorporarcd cithrr in NEM or DTT (lo,5 /rg prorcin) were treated cithcr with NEM (a, c) or with DTT(b, 
trcatmcnt. M, srandards are shown (myosin, 200 kDa; rrz+xxro- d) and clccrrophorcscd as dcscribcd. The open symbols show Lhc 
globulin, I70 kDn; fl.gnlactoridasc, I16 kDa; phosphorylasc 0, samples photolyzed in the presence of IO&I (&)PN200-110, 
97 kDa; bovine serum albumin, 66 kDa; glutamate dchydrogcnasc, Radioactivity in the gel slices up to 20 arc shown here; no 
55 kDa; ovnlbumin, 45 kDa; lactate dchydrogcnasc, 36 kDa), radioactivity \VFIS observed in the following gel slices, 
(Fig. SC), although both of the compounds are In conclusion, diazipine has considerable advantages 
estimated to bind reversibly to a similar extent (30010) of over conventional azidopine as a photoaffinity probe 
the DHP receptors before irradiation. Under the condi- for L-type calcium channels: higher yield of photain- 
tions of irradiation, W’o of the bound [3H]diazipine was corporation, forming more stable photoproduct( 
photoincorporated. Moreover, the photoincorporated although binding affinity is similar. It will now provide 
amount of [3Hldiazipine into the ~4 subunit of the us a more suitable tool to identify the binding site of the 
calcium channel did not change after the DTT reduc- dihydropyridine in the calcium channels, 
lion, as shown in Fig. 5 (a,b). This is in clear contrast 
to the result of [3W]azidopine that the photoinco,r- Ackrrow/edgements: We thank Dr H. Glossmann for his reading and 
porated amount decreased by 33% (Fig. 5c,d), or even comments on the manuscript. This work was supported by Grants-in- 
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diazipine, forms more stable photoproducts against 
DTT reduction than the ghenylnitrene from the 
phenylazide group of azidopine. It is worth nbting that REFERENCES 
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